JPWO2023108126A5 - - Google Patents

Info

Publication number
JPWO2023108126A5
JPWO2023108126A5 JP2023574593A JP2023574593A JPWO2023108126A5 JP WO2023108126 A5 JPWO2023108126 A5 JP WO2023108126A5 JP 2023574593 A JP2023574593 A JP 2023574593A JP 2023574593 A JP2023574593 A JP 2023574593A JP WO2023108126 A5 JPWO2023108126 A5 JP WO2023108126A5
Authority
JP
Japan
Prior art keywords
polypeptide
construct
polypeptide construct
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545981A (ja
JP2024545981A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081277 external-priority patent/WO2023108126A1/en
Publication of JP2024545981A publication Critical patent/JP2024545981A/ja
Publication of JPWO2023108126A5 publication Critical patent/JPWO2023108126A5/ja
Publication of JP2024545981A5 publication Critical patent/JP2024545981A5/ja
Pending legal-status Critical Current

Links

JP2023574593A 2021-12-11 2022-12-09 経口投与のための組成物および方法 Pending JP2024545981A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163288579P 2021-12-11 2021-12-11
US63/288,579 2021-12-11
PCT/US2022/081277 WO2023108126A1 (en) 2021-12-11 2022-12-09 Compositions and methods for oral administration

Publications (3)

Publication Number Publication Date
JP2024545981A JP2024545981A (ja) 2024-12-17
JPWO2023108126A5 true JPWO2023108126A5 (https=) 2026-01-28
JP2024545981A5 JP2024545981A5 (https=) 2026-01-28

Family

ID=86731317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574593A Pending JP2024545981A (ja) 2021-12-11 2022-12-09 経口投与のための組成物および方法

Country Status (11)

Country Link
US (1) US20250388638A1 (https=)
EP (1) EP4444352A4 (https=)
JP (1) JP2024545981A (https=)
KR (1) KR20240141165A (https=)
CN (1) CN118613284A (https=)
AU (1) AU2022405604A1 (https=)
CA (1) CA3235948A1 (https=)
IL (1) IL312382A (https=)
MX (1) MX2024007105A (https=)
WO (1) WO2023108126A1 (https=)
ZA (1) ZA202404443B (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US20070042392A1 (en) * 2000-02-03 2007-02-22 Nuvelo, Inc. Novel nucleic acids and polypeptides
KR100944034B1 (ko) * 2007-04-19 2010-02-24 한올제약주식회사 프로테아제-내성 폴리펩티드의 경구 투여 제형
KR102497242B1 (ko) * 2016-11-13 2023-02-09 이매진 파마 당뇨병, 고혈압 및 고콜레스테롤혈증을 치료하기 위한 조성물 및 방법
PL3746111T3 (pl) * 2018-02-02 2024-01-15 Novo Nordisk A/S Stałe kompozycje zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino kaprylowego i substancję poślizgową

Similar Documents

Publication Publication Date Title
US11866477B2 (en) GLP-1 analogues
JP5890085B2 (ja) 生理学的pHの緩衝液中で向上した溶解度を示すグルカゴン類縁体
TWI489992B (zh) 醯胺系胰高血糖素超級家族之胜肽前驅藥物
JP4585037B2 (ja) アシル化glp−1化合物
JP5606314B2 (ja) A−b−c−d−で誘導体化されたペプチドとその治療用途
EP2900255B1 (en) Insulin analog dimers
AU2004298424A1 (en) Novel GLP-1 compounds
JP2007056023A (ja) 親油性のペプチドホルモン誘導体
KR20110114568A (ko) 디펩티드 링크된 약효 물질
CN104302772A (zh) 用于糖尿病治疗的蛋白、蛋白缀合物及其应用
WO2010134537A1 (ja) 細胞膜透過性ペプチド
JPH06228199A (ja) 血液脳関門通過可能なペプチド結合体
US7595294B2 (en) Vasoactive intestinal polypeptide pharmaceuticals
WO2013086786A1 (zh) 具有降血糖作用的化合物、组合物及其用途
AU2005294125A1 (en) Vasoactive intestinal polypeptide pharmaceuticals
TWI688406B (zh) 與白蛋白具有較佳結合親和力之藥物分子
US20040127418A1 (en) GLP-2 derivatives
JPWO2023108126A5 (https=)
US11807672B2 (en) Conjugates of islet neogenesis peptides and analogs, and methods thereof
JP2009502976A (ja) 親水性ペプチド鎮痛薬の経口送達のためのペプチドコンジュゲート
HK40086836A (en) Novel glp-1 analogues
HK40086836B (en) Novel glp-1 analogues
HK40044876B (en) Novel glp-1 analogues
HK40044876A (en) Novel glp-1 analogues
JP2007143454A (ja) 細胞膜通過性ペプチド